Background
Methods
Study design, setting, and participants
Data collection
Cohort definitions
Outcome definitions
Statistical analysis
Results
Characteristic | Overall | Included | Excluded | P value |
---|---|---|---|---|
(n = 671) | (n = 562) | (n = 109) | ||
Age (yr) | 47.9 (15.2) | 48.0 (15.0) | 47.1 (16.4) | 0.55 |
Female sex | 363 (54.1) | 300 (53.4) | 63 (57.8) | 0.40 |
Ethnicity (n=652, 555, 97) | ||||
White/Caucasian | 378 (58.0) | 327 (58.9) | 51 (52.6) | 0.41 |
Unknown/Mixed/Other | 143 (21.9) | 117 (21.1) | 26 (26.8) | |
Aboriginal | 85 (13.0) | 74 (13.3) | 11 (11.3) | |
Asian | 46 (7.1) | 37 (6.7) | 9 (9.3) | |
Any co-morbidity | 607 (90.5) | 513 (91.3) | 94 (86.2) | 0.10 |
Obesity | 167 (24.9) | 150 (26.7) | 17 (15.6) | 0.01 |
Diabetes mellitus | 170 (25.3) | 146 (26.0) | 24 (22.0) | 0.38 |
Chronic obstructive pulmonary disease | 119 (17.7) | 98 (17.4) | 21 (19.3) | 0.65 |
Alcohol abuse | 83 (12.4) | 74 (13.2) | 9 (8.3) | 0.15 |
Chronic kidney disease | 56 (8.4) | 48 (8.5) | 8 (7.3) | 0.68 |
H1N1 status | ||||
Confirmed | 574 (85.5) | 479 (85.2) | 95 (87.2) | 0.60 |
Probable | 97 (14.5) | 83 (14.8) | 14 (12.8) | |
Days of symptoms pre-hospital (n = 635, 532, 103) | 4.0 (2.0-7.0) | 4.0 (2.0-7.0) | 3.0 (1.0-6.0) | 0.01 |
Days of symptoms pre-ICU (n = 653, 549, 104) | 5.0 (3.0-8.0) | 5.0 (3.0-8.0) | 4.5 (2.5-7.0) | 0.04 |
Day 1 support,
physiology,
and laboratory values
| ||||
APACHE II score (n = 594, 508, 86) | 20.8 (9.8) | 21.1 (9.2) | 19.1 (13.1) | 0.19 |
SOFA score (n = 411, 361, 50) | 11.2 (3.7) | 11.2 (3.8) | 10.9 (3.6) | 0.61 |
Invasive mechanical ventilation (n = 652, 553, 99) | 431 (66.1) | 384 (69.4) | 47 (47.5) | <0.0001 |
Inotrope or vasopressor | 281 (41.9) | 251 (44.7) | 30 (27.5) | 0.0009 |
Mean arterial pressure (mmHg) (n = 613, 522, 91) | 74.1 (18.7) | 74.4 (18.9) | 72.5 (17.4) | 0.37 |
Heart rate (beats/min) (n = 504, 433, 71) | 104.1 (24.0) | 104.5 (24.1) | 101.5 (23.3) | 0.33 |
Temperature (°C) (n = 472, 405, 67) | 37.6 (1.3) | 37.6 (1.2) | 37.5 (1.8) | 0.48 |
PaO2/FiO2 (n = 570, 496, 74) | 160 (120) | 153 (96) | 212 (215) | 0.02 |
CK (U/L) (n = 270, 230, 40) | 272 (91-776) | 293 (91-835) | 224 (87-663) | 0.41 |
CK > 5000 IU/L (n = 270, 230, 40) | 15 (5.6) | 13 (5.7) | 2 (5.0) | 1.00 |
WBC (109/L) (n = 471, 409, 62) | 9.7 (6.5) | 9.5 (6.5) | 10.6 (7.0) | 0.24 |
Albumin (g/L) (n = 315, 275, 40) | 26.6 (7.2) | 26.2 (7.0) | 28.7 (8.0) | 0.04 |
Platelets (109/L) (n = 608, 520, 88) | 190 (96) | 188 (96) | 204 (95) | 0.16 |
Urea (mmol/L) (n = 89, 76, 13) | 10.2 (19.7) | 10.5 (21.0) | 8.4 (9.4) | 0.56 |
Creatinine (μmol/L) (n = 626, 537, 89) | 125 (120) | 124 (120) | 131 (119) | 0.59 |
Urine output (mL/24 hr) (n = 489, 431, 58) | 1440 (1082) | 1439 (1055) | 1446 (1278) | 0.97 |
Interventions
(ICU day 1,
3,
7,
14,
or 28)
| ||||
Renal replacement therapy (n = 670, 561, 109) | 91 (13.6) | 85 (15.2) | 6 (5.5) | 0.007 |
Invasive mechanical ventilation (n = 669, 562, 107) | 568 (84.9) | 499 (88.8) | 69 (64.5) | <0.0001 |
Inotropes or vasopressors | 373 (55.6) | 339 (60.3) | 34 (31.2) | <0.0001 |
Antiviral treatment | 620 (92.4) | 530 (94.3) | 90 (82.6) | <0.0001 |
Outcome
| ||||
Days of ICU stay (n = 640, 539, 101) | 11.0 (6.0-19.0) | 11.0 (7.0-20.0) | 5.0 (2.0-13.0) | <0.0001 |
Days of hospital stay (n = 626, 523, 103) | 18.0 (11.0-34.0) | 19.0 (12.0-35.0) | 12.0 (5.0-24.0) | <0.0001 |
Hospital mortality (n = 649, 545, 104) | 142 (21.9) | 113 (20.7) | 29 (27.9) | 0.11 |
Characteristic | Overall | AKI | No AKI | P value |
---|---|---|---|---|
(n = 562) | (n = 342) | (n = 220) | ||
Age (yr) | 48.0 (15.0) | 49.1 (15.1) | 46.4 (14.8) | 0.03 |
Female sex | 300 (53.4) | 177 (51.8) | 123 (55.9) | 0.34 |
Ethnicity (n=555, 336, 219) | 0.23 | |||
White/Caucasian | 327 (58.9) | 204 (60.7) | 123 (56.2) | |
Unknown/Mixed/Other | 117 (21.1) | 68 (20.2) | 49 (22.4) | |
Aboriginal | 74 (13.3) | 47 (14.0) | 27 (12.3) | |
Asian | 37 (6.7) | 17 (5.1) | 20 (9.1) | |
Any co-morbidity | 513 (91.3) | 316 (92.4) | 197 (89.6) | 0.24 |
Obesity | 150 (26.7) | 118 (34.5) | 32 (14.6) | <0.0001 |
Diabetes mellitus | 146 (26.0) | 107 (31.3) | 39 (17.7) | 0.0003 |
Chronic obstructive pulmonary disease | 98 (17.4) | 56 (16.4) | 42 (19.1) | 0.41 |
Alcohol abuse | 74 (13.2) | 41 (12.0) | 33 (15.0) | 0.30 |
Chronic kidney disease | 48 (8.5) | 44 (12.9) | 4 (1.8) | <0.0001 |
H1N1 status | ||||
Confirmed | 479 (85.2) | 291 (85.1) | 188 (85.5) | 0.90 |
Probable | 83 (14.8) | 51 (14.9) | 32 (14.6) | |
Days of symptoms pre-hospital (n = 532, 326, 206) | 4.0 (2.0-7.0) | 4.0 (2.0-7.0) | 4.0 (2.0-7.0) | 0.67 |
Days of symptoms pre-ICU (n = 549, 336, 213) | 5.0 (3.0-8.0) | 5.0 (3.0-8.0) | 5.0 (3.0-8.0) | 0.66 |
Overall | AKI | No AKI | P value | |
---|---|---|---|---|
(n = 562) | (n = 342) | (n = 220) | ||
Day 1 support,
physiology,
and laboratory values
| ||||
APACHE II score (n = 508, 306, 202) | 21.1 (9.2) | 23.0 (9.6) | 18.1 (7.6) | <0.0001 |
SOFA score (n = 361, 216, 145) | 11.2 (3.8) | 12.0 (3.8) | 9.7 (3.2) | <0.0001 |
Invasive mechanical ventilation (n = 553, 338, 215) | 384 (69.4) | 241 (71.3) | 143 (66.5) | 0.23 |
Inotrope or vasopressor | 251 (44.7) | 164 (48.0) | 87 (39.6) | 0.05 |
Mean arterial pressure (mmHg) (n = 522, 315, 207) | 74 (19) | 73 (19) | 76 (19) | 0.14 |
Heart rate (beats/min) (n = 433, 262, 171) | 104 (24) | 106 (25) | 102 (22) | 0.07 |
Temperature (°C) (n = 405, 244, 161) | 37.6 (1.2) | 37.6 (1.3) | 37.7 (1.2) | 0.84 |
PaO2/FiO2 (n = 496, 299, 197) | 153 (96) | 143 (94) | 167 (98) | 0.006 |
CK (U/L) (n = 230, 137, 93) | 293 (91-835) | 320 (102-949) | 206 (90-681) | 0.08 |
CK > 5000 IU/L (n = 230, 137, 93) | 13 (5.7) | 10 (7.3) | 3 (3.2) | 0.19 |
WBC (109/L) (n = 409, 243, 166) | 9.6 (6.5) | 9.7 (6.8) | 9.3 (6.0) | 0.45 |
Albumin (g/L) (n = 275, 167, 108) | 26.2 (7.0) | 26.1 (7.1) | 26.4 (7.0) | 0.77 |
Platelets (109/L) (n = 520, 313, 207) | 188 (96) | 184 (95) | 194 (96) | 0.26 |
Urea (mmol/L) (n = 76, 44, 32) | 10.5 (21.0) | 14.4 (26.9) | 5.1 (2.8) | 0.03 |
Creatinine (μmol/L) (n = 537, 326, 211) | 124 (120) | 155 (144) | 76 (31) | <0.0001 |
Urine output (mL/24 hr) (n = 431, 270, 161) | 1439 (1055) | 1070 (939) | 2058 (946) | <0.0001 |
Clinical course and outcomes
| ||||
Invasive mechanical ventilation | 499 (88.8) | 313 (91.5) | 186 (84.6) | 0.01 |
Inotropes or vasopressors | 339 (60.3) | 222 (64.9) | 117 (53.2) | 0.006 |
Antiviral treatment | 530 (94.3) | 326 (95.3) | 204 (92.7) | 0.20 |
Renal replacement therapy (n = 561, 342, 219) | 85 (15.2) | 85 (24.9) | 0 | <0.0001 |
Days of hospital stay (n = 523, 319, 204) | 19.0 (12.0-35.0) | 20.0 (12.0-40.0) | 17.0 (12.0-30.0) | 0.13 |
Days of ICU stay (n = 539, 325, 214) | 11.0 (7.0-20.0) | 12.0 (7.0-24.0) | 10.0 (6.0-16.0) | 0.002 |
Hospital mortality (n = 545, 329, 216) | 113 (20.7) | 85 (25.8) | 28 (13.0) | 0.0003 |
Incidence, characteristics, and predictors of AKI
Primary analysis, with baseline glomerular filtration rate estimated as 75 ml/min/1.73 m2
| Incidence | Hospital mortality1, 2
|
---|---|---|
(n = 562) | ||
No AKI | 220 (39.1) | 28/216 (13.0) |
None | 181 (32.2) | 21/178 (11.8) |
Risk | 39 (6.9) | 7/38 (18.4) |
AKI | 342 (60.9) | 85/329 (25.8) |
Injury | 129 (23.0) | 20/125 (16.0) |
Failure | 213 (37.9) | 65/204 (31.9) |
Renal replacement therapy, n = 561 | 85 (15.1) | 26/84 (31.0) |
Injury | 3 (0.5%) | 3/3 (100) |
Failure | 82 (14.6%) | 26/81 (31.0%) |
Sensitivity analysis 1,
assuming that first available serum creatinine is the baseline
|
n = 537
| |
No AKI | 269 (50.1) | 45/262 (17.2) |
None | 221 (41.2) | 26/217 (12.0) |
Risk | 48 (8.9) | 19/45 (42.2) |
AKI | 268 (49.9) | 64/259 (24.7) |
Injury | 253 (47.1) | 61/244 (25.0) |
Failure | 15 (2.8) | 3/15 (20.0) |
Sensitivity analysis 2,
assuming that lowest observed serum creatinine at any time is the baseline
|
n = 562
| |
No AKI | 218 (38.8) | 27/214 (12.6) |
None | 194 (34.5%) | 25/191 (13.1) |
Risk | 24 (4.2%) | 2/23 (8.7) |
AKI | 344 (61.2) | 86/331 (26.0) |
Injury | 118 (21.0%) | 15/114 (13.2) |
Failure3
| 226 (40.2%) | 71/217 (32.7) |
Variable | AKI | No AKI | Crude OR | P value | Adjusted OR | P value |
---|---|---|---|---|---|---|
n = 342 | n = 220 | (95% CI) | (95% CI) | |||
H1N1 details,
demographics,
and comorbidities
| ||||||
Confirmed H1N1 | 291 (85.1) | 188 (85.5) | 0.97 (0.60-1.57) | 0.90 | ||
Age (yr) | 49.1 (15.1) | 46.4 (14.8) | 1.01 (1.00-1.02) | 0.03 | 1.00 (0.98-1.02) | 0.98 |
Female sex | 177 (51.8) | 123 (55.9) | 0.85 (0.60-1.19) | 0.34 | 0.86 (0.56-1.32) | 0.50 |
Ethnicity (n = 555, 336, 219) | ||||||
White/Caucasian (reference) | 204 (60.7) | 123 (56.2) | 1.00 | 1.00 | ||
Unknown/Mixed/ Other | 68 (20.2) | 49 (22.4) | 0.84 (0.54-1.29) | 0.42 | 0.80 (0.46- 1.39) | 0.43 |
Aboriginal | 47 (14.0) | 27 (12.3) | 1.05 (0.62-1.77) | 0.86 | 1.01 (0.52-1.94) | 0.98 |
Asian | 17 (5.1) | 20 (9.1) | 0.51 (0.26-1.02) | 0.06 | 0.82 (0.35-1.89) | 0.64 |
Obesity | 118 (34.5) | 32 (14.6) | 3.10 (2.00-4.79) | <0.0001 | 2.94 (1.75-4.91) | <0.0001 |
Diabetes mellitus | 107 (31.3) | 39 (17.7) | 2.11 (1.40-3.20) | 0.0004 | 1.61 (0.96-2.69) | 0.07 |
Chronic obstructive pulmonary disease | 56 (16.4) | 42 (19.1) | 0.83 (0.53-1.29) | 0.41 | ||
Alcohol abuse | 41 (12.0) | 33 (15.0) | 0.77 (0.47-1.26) | 0.30 | ||
Chronic kidney disease | 44 (12.9) | 4 (1.8) | 7.97 (2.82-22.5) | <0.0001 | 4.50 (1.46-13.82) | 0.009 |
Day 1 support,
physiology,
and laboratory values
| ||||||
APACHE II score (n = 508, 306, 202) | 23.0 (9.6) | 18.1 (7.6) | 1.07 (1.04-1.09) | <0.0001 | 1.06 (1.03- 1.09) | <0.0001 |
Invasive mechanical ventilation (n = 553, 338, 215) | 241 (71.3) | 143 (66.5) | 1.25 (0.86-1.81) | 0.23 | ||
Inotrope or vasopressor | 164 (48.0) | 87 (39.6) | 1.41 (1.00-1.99) | 0.05 | 1.29 (0.82-2.01) | 0.27 |
Mean arterial pressure (mmHg) (n = 522, 315, 207) | 73.4 (18.7) | 75.9 (19.2) | 0.93 (0.85-1.02) | 0.14 | 0.95 (0.85-1.06) | 0.32 |
PaO2/FiO2 (n = 496, 299, 197) | 143 (94) | 167 (98) | 0.97 (0.96-0.99) | 0.007 | 0.98 (0.95- 1.00) | 0.04 |
Platelets (109/L) (n = 520, 313, 207) | 184 (95) | 194 (96) | 0.99 (0.97-1.01) | 0.26 |
Clinical course and outcomes
Variable | RRT | No RRT | Crude OR | P value | Adjusted OR | P value |
---|---|---|---|---|---|---|
n = 85 | n = 476 | (95% CI) | (95% CI) | |||
Demographics and comorbidities
| ||||||
Age (yr) | 46.2 (13.1) | 48.4 (15.3) | 0.99 (0.98-1.01) | 0.21 | 0.98 (0.96-1.00) | 0.07 |
Female sex | 43 (50.6) | 256 (53.8) | 0.88 (0.55-1.40) | 0.59 | 1.81 (0.91-3.58) | 0.09 |
Ethnicity (n = 554, 85, 469) | ||||||
White/Caucasian (reference) | 56 (65.9) | 271 (57.8) | 1.00 | 1.00 | ||
Unknown/Other | 19 (22.4) | 97 (20.7) | 0.95 (0.54-1.68) | 0.85 | 0.53 (0.22-1.28) | 0.16 |
Aboriginal | 6 (7.1) | 68 (14.5) | 0.43 (0.18-1.03) | 0.06 | 0.40 (0.13-1.20) | 0.10 |
Asian | 4 (4.7) | 33 (7.0) | 0.59 (0.20-1.7) | 0.33 | 1.11 (0.31-3.95) | 0.88 |
Obesity | 33 (38.8) | 117 (24.6) | 1.95 (1.20-3.16) | 0.007 | 2.25 (1.14-4.44) | 0.02 |
Diabetes mellitus | 23 (27.1) | 123 (25.8) | 1.06 (0.63-1.79) | 0.81 | ||
Chronic obstructive pulmonary disease | 5 (5.9) | 93 (19.5) | 0.26 (0.10-0.65) | 0.004 | 0.26 (0.06-1.20) | 0.08 |
Alcohol abuse | 10 (11.8) | 64 (13.5) | 0.86 (0.42-1.75) | 0.67 | ||
Chronic kidney disease | 15 (17.7) | 33 (6.9) | 2.88 (1.49-5.57) | 0.002 | 0.85 (0.28-2.57) | 0.78 |
Day 1 support,
physiology,
and laboratory values
| ||||||
APACHE II score (n = 507, 80, 427) | 27.6 (9.2) | 19.8 (8.6) | 1.10 (1.07-1.13) | <0.0001 | 1.07 (1.03-1.12) | 0.0009 |
Invasive mechanical ventilation (n = 552, 85, 467) | 72 (84.7) | 311 (66.6) | 2.78 (1.49-5.17) | 0.001 | 4.09 (1.21-13.84) | 0.02 |
Inotrope or vasopressor | 44 (51.8) | 206 (43.3) | 1.41 (0.89-2.23) | 0.15 | 0.78 (0.37-1.61) | 0.50 |
Mean arterial pressure (mmHg) (n = 521, 79, 442) | 70.4 (16.9) | 75.2 (19.2) | 0.87 (0.76-0.995) | 0.04 | 0.97 (0.81–1.16) | 0.75 |
PaO2/FiO2 (n = 495, 76, 419) | 132 (95) | 156 (96) | 0.97 (0.94-1.00) | 0.046 | 0.97 (0.93-1.01) | 0.16 |
Platelets (109/L) (n = 519, 76, 443) | 164 (84) | 192 (96) | 0.97 (0.94-0.995) | 0.02 | 0.99 (0.95-1.03) | 0.64 |
Creatinine (μmol/L) (n = 536, 79, 457) | 233 (185) | 105 (93) | 1.07 (1.05-1.09) | <0.0001 | 1.06 (1.03-1.10) | <0.0001 |
Variable | Deaths | Survivors | Crude OR | P value | Adjusted OR | P value |
---|---|---|---|---|---|---|
(n = 113) | (n = 432) | (95% CI) | (95% CI) | |||
H1N1 details, demographics, and comorbidities
| ||||||
Confirmed H1N1 | 104 (92.0) | 364 (84.3) | 2.16 (1.04-4.47) | 0.04 | 1.59 (0.66-3.80) | 0.30 |
Days of symptoms before hospitalization | 5.5 (5.5) | 5.2 (4.6) | 1.01 (0.97-1.06) | 0.55 | ||
Days of symptoms before ICU admission (n = 534, 110, 424) | 7.2 (6.5) | 6.2 (5.1) | 1.03 (1.00-1.07) | 0.08 | 1.04 (1.00-1.09) | 0.06 |
Age (yr) | 51.8 (15.6) | 47.0 (14.6) | 1.02 (1.01-1.04) | 0.003 | 1.02 (1.00-1.04) | 0.03 |
Female sex | 55 (48.7) | 234 (54.2) | 0.80 (0.53-1.22) | 0.30 | 1.00 (0.58-1.71) | 0.99 |
Obesity | 42 (37.2) | 106 (24.5) | 1.82 (1.17-2.82) | 0.008 | 1.49 (0.85-2.62) | 0.16 |
Diabetes mellitus | 24 (21.2) | 116 (26.9) | 0.74 (0.45-1.21) | 0.23 | ||
Chronic obstructive pulmonary disease | 20 (17.7) | 75 (17.4) | 1.02 (0.60-1.76) | 0.93 | ||
Alcohol abuse | 9 (8.0) | 64 (14.8) | 0.50 (0.24-1.03) | 0.06 | 0.77 (0.34-1.75) | 0.54 |
Chronic kidney disease | 15 (13.3) | 33 (7.6) | 1.85 (0.97-3.54) | 0.06 | 1.35 (0.50-3.61) | 0.55 |
Day 1 support, physiology, and laboratory parameters
| ||||||
APACHE II (n = 497, 101, 396) | 25.0 (10.2) | 20.0 (8.6) | 1.06 (1.04-1.09) | <0.0001 | 1.05 (1.01-1.08) | 0.006 |
Invasive mechanical ventilation (n = 537, 111, 426) | 82 (73.9) | 289 (67.8) | 1.34 (0.84-2.14) | 0.22 | ||
Inotrope or vasopressor | 52 (46.0) | 186 (43.1) | 1.13 (0.74-1.71) | 0.57 | ||
Mean arterial pressure (mmHg) (n = 506, 103, 403) | 75.1 (20.9) | 74.2 (18.6) | 1.02 (0.91-1.14) | 0.70 | ||
PaO2/FiO2 (n = 480, 101, 379) | 126 (84) | 161 (99) | 0.95 (0.93-0.98) | 0.002 | 0.95 (0.92-0.99) | 0.007 |
Creatinine (μmol/L) (n = 521, 109, 412) | 159 (127) | 115 (118) | 1.03 (1.01-1.04) | 0.002 | 1.001 (0.98-1.03) | 0.95 |
Platelets (109/L) (n = 504, 105, 399) | 151 (93) | 196 (91) | 0.94 (0.91-0.97) | <0.0001 | 0.92 (0.89-0.96) | <0.0001 |
Other
| ||||||
Acute kidney injury | 85 (75.2) | 244 (56.5) | 2.34 (1.47-3.73) | 0.0004 | 1.35 (0.74-2.48) | 0.33 |